Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer
14 Visualizzazioni
• 07/14/23
0
0
Incorporare
administrator
Iscritti
David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).
More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti